Results about: Alumni
Ana Janic received her PhD in 2011 after completing her her doctoral studies in Cayetano González’s Cell Division Laboratory.
The jury for the prize acknowledges the outstanding quality of Ana Janic’s scientific contributions and her seniority along her career.
The Institute has signed a 5-year collaboration agreement to promote the exchange of faculty members and scientific collaboration with the Hokkaido University.
The jury highlights the relevance of his findings for the cancer research field.
Font-Burgada has been Assistant Professor in the Cancer Biology Program at the Fox Chase Cancer Center in Philadelphia since 2017.
Researchers discover activators of a potential therapeutic target for the treatment of patients with diabetes and insulin resistance
A team headed by Antonio Zorzano at IRB Barcelona has identified activators of the mitochondrial protein Mitofusin 2 for the treatment of type 2 diabetes.
The protein is a key regulator of many mitochondrial functions, as well as of the cell as a whole.
Xavier Salvatella, ICREA researcher at IRB Barcelona, proposes a new approach to combat prostate tumour cells that have become unresponsive to the treatments currently available.
The incidence of prostate cancer is increasing worldwide. In the US and Europe, it is one of the most common tumours and among the main causes of death by cancer.
“After 10+ years at IRB, the idea of 'together we can make great things happen' is going to stick with me,” says Francisco Lozano
Many moons have passed since 2006 when Francisco Lozano (b. Madrid, 1968, better known as Curro) moved to a recently launched IRB Barcelona to head the Information Technology Services. Thanks to Curro and his team's contributions over eleven years, IRB Barcelona now boasts developed IT strategies and state-of-the-art, competitive technologies and clusters. He has recently embarked on his next career move: the International Agency for Research on Cancer (IARC) of the World Health Organization in Lyon (France) has hired him as their Head of Information Technology Services.
After spending three years as a Visiting Student in the Complex Metabolic Diseases and Mitochondria Lab led by Antonio Zorzano, Jordi Coste (b. Barcelona, 1993) is about to embark on new projects in the United States. This young scientist is leaving behind what he considers “a big family” at IRB Barcelona to pursue a career more focused on clinical counselling. But before crossing the pond, he has found time to look back on his years with us: “The Institute has helped me to improve my critical and logical thinking skills, and this will definitely help me in the future.”